Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05019456Active, not recruiting
Open-label, single-arm trial, sponsored by University of Arizona. Primary endpoints: Interferon-gamma concentration, Interferon-gamma spot forming cells and 3 more. Started Mar 2021; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05019456.